IL6 and cancer: Consistent with these findings, co-culture of CD10+GPR77+ CAFs with cancer cells dramatically enhanced survival upon treatment with cisplatin or docetaxel, by providing a constant source of paracrine IL-6 and IL-8 that stimulates the survival of cancer stem cells in the TME, ultimately inducing chemoresistance.